Drugs / Oxycodone/Naloxone
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01427283 | Aug 2011 → Oct 2014 | — | Purdue Pharma LP | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Oxycodone/Naloxone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01427283 ↗ |
| Known as | OXN | “Oxycodone/Naloxone controlled-release tablets (OXN)” NCT01427283 ↗ |
| Route | Oral | “Oxycodone/Naloxone controlled-release tablets (10/5 - 40/20 mg) taken orally every 12 hours” NCT01427283 ↗ |